FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2762548968> ?p ?o ?g. }

• W2762548968 endingPage "501" @default.
• W2762548968 startingPage "494" @default.
• W2762548968 abstract "Optimal valve substitute for young patients with aortic valve endocarditis remains controversial. Given its better resistance to infection, the Ross procedure is an attractive alternative to prosthetic valve replacement or homograft implantation. The objective of this study was to assess long-term outcomes of the Ross procedure in this indication. From January 1991 to April 2017, 190 patients underwent a Ross procedure at our institution. Acute endocarditis was the indication for operation in 19 patients, including 6 patients with a bicuspid aortic valve. The pulmonary autograft was implanted as freestanding root replacement in all patients. The clinical follow-up is 100% complete, with a mean of 12.0 ± 5.7 years. The mean age of the study population was 35.9 ± 11.5 years. Moderate or severe aortic regurgitation was present in 84.2% of the patients. Systemic embolization had occurred in 36.8% of the patients. The mean aortic cross-clamp time was 126 ± 24 minutes. The median length of stay on the intensive care unit was 1 day. Mortality at 30 days was 5.3% (1 patient with gastrointestinal bleeding). Echocardiography at hospital discharge documented no or trivial aortic regurgitation in all patients. No case of recurrent endocarditis affecting the autograft occurred. One patient (0.4% per patient-year) was reoperated 1.8 years after the Ross procedure for homograft endocarditis. Three patients (15.8%) were reoperated for autograft aneurysm. The Ross procedure is a safe and effective alternative to prosthetic valve replacement or homograft implantation in selected young patients with acute endocarditis with a low rate of recurrent infection. Optimal valve substitute for young patients with aortic valve endocarditis remains controversial. Given its better resistance to infection, the Ross procedure is an attractive alternative to prosthetic valve replacement or homograft implantation. The objective of this study was to assess long-term outcomes of the Ross procedure in this indication. From January 1991 to April 2017, 190 patients underwent a Ross procedure at our institution. Acute endocarditis was the indication for operation in 19 patients, including 6 patients with a bicuspid aortic valve. The pulmonary autograft was implanted as freestanding root replacement in all patients. The clinical follow-up is 100% complete, with a mean of 12.0 ± 5.7 years. The mean age of the study population was 35.9 ± 11.5 years. Moderate or severe aortic regurgitation was present in 84.2% of the patients. Systemic embolization had occurred in 36.8% of the patients. The mean aortic cross-clamp time was 126 ± 24 minutes. The median length of stay on the intensive care unit was 1 day. Mortality at 30 days was 5.3% (1 patient with gastrointestinal bleeding). Echocardiography at hospital discharge documented no or trivial aortic regurgitation in all patients. No case of recurrent endocarditis affecting the autograft occurred. One patient (0.4% per patient-year) was reoperated 1.8 years after the Ross procedure for homograft endocarditis. Three patients (15.8%) were reoperated for autograft aneurysm. The Ross procedure is a safe and effective alternative to prosthetic valve replacement or homograft implantation in selected young patients with acute endocarditis with a low rate of recurrent infection. Do the Best Until We Know Better…Seminars in Thoracic and Cardiovascular SurgeryVol. 29Issue 4PreviewCardiac valve replacement in children and young patients challenges the continuing improvements in the management of congenital and acquired heart disease still being far away from offering the perfect solution. The need for the readily available heart valve substitute with life-long functional and structural integrity as well as natural growth potential without the need for additional anticoagulation is on the top list of cardiovascular research. Meticulous analysis of long-term outcomes of existing valve substitutes will aid to draw the route for the development of optimal solutions particularly for the young patient population. Full-Text PDF" @default.
• W2762548968 created "2017-10-20" @default.
• W2762548968 creator A5003289129 @default.
• W2762548968 creator A5033026314 @default.
• W2762548968 creator A5037754945 @default.
• W2762548968 creator A5066557451 @default.
• W2762548968 creator A5081518564 @default.
• W2762548968 creator A5084740463 @default.
• W2762548968 creator A5089687495 @default.
• W2762548968 date "2017-01-01" @default.
• W2762548968 modified "2023-10-03" @default.
• W2762548968 title "Long-term Evaluation of the Ross Procedure in Acute Infective Endocarditis" @default.
• W2762548968 cites W1961831464 @default.
• W2762548968 cites W1967114575 @default.
• W2762548968 cites W1968225884 @default.
• W2762548968 cites W1981968197 @default.
• W2762548968 cites W1997903784 @default.
• W2762548968 cites W2013859018 @default.
• W2762548968 cites W2032109584 @default.
• W2762548968 cites W2036174331 @default.
• W2762548968 cites W2041400884 @default.
• W2762548968 cites W2051442979 @default.
• W2762548968 cites W2059897957 @default.
• W2762548968 cites W2069042755 @default.
• W2762548968 cites W2087658540 @default.
• W2762548968 cites W2091192813 @default.
• W2762548968 cites W2099859937 @default.
• W2762548968 cites W2102369933 @default.
• W2762548968 cites W2102922451 @default.
• W2762548968 cites W2106925435 @default.
• W2762548968 cites W2115407923 @default.
• W2762548968 cites W2119516274 @default.
• W2762548968 cites W2124355041 @default.
• W2762548968 cites W2127577244 @default.
• W2762548968 cites W2147834564 @default.
• W2762548968 cites W2156451821 @default.
• W2762548968 cites W2157596892 @default.
• W2762548968 cites W2158761529 @default.
• W2762548968 cites W2164955726 @default.
• W2762548968 cites W2181764772 @default.
• W2762548968 cites W2325939165 @default.
• W2762548968 doi "https://doi.org/10.1053/j.semtcvs.2017.09.010" @default.
• W2762548968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28987279" @default.
• W2762548968 hasPublicationYear "2017" @default.
• W2762548968 type Work @default.
• W2762548968 sameAs 2762548968 @default.
• W2762548968 citedByCount "19" @default.
• W2762548968 countsByYear W27625489682017 @default.
• W2762548968 countsByYear W27625489682018 @default.
• W2762548968 countsByYear W27625489682019 @default.
• W2762548968 countsByYear W27625489682020 @default.
• W2762548968 countsByYear W27625489682021 @default.
• W2762548968 countsByYear W27625489682022 @default.
• W2762548968 crossrefType "journal-article" @default.
• W2762548968 hasAuthorship W2762548968A5003289129 @default.
• W2762548968 hasAuthorship W2762548968A5033026314 @default.
• W2762548968 hasAuthorship W2762548968A5037754945 @default.
• W2762548968 hasAuthorship W2762548968A5066557451 @default.
• W2762548968 hasAuthorship W2762548968A5081518564 @default.
• W2762548968 hasAuthorship W2762548968A5084740463 @default.
• W2762548968 hasAuthorship W2762548968A5089687495 @default.
• W2762548968 hasConcept C126322002 @default.
• W2762548968 hasConcept C141071460 @default.
• W2762548968 hasConcept C164705383 @default.
• W2762548968 hasConcept C2775872228 @default.
• W2762548968 hasConcept C2776376669 @default.
• W2762548968 hasConcept C2776570981 @default.
• W2762548968 hasConcept C2779303622 @default.
• W2762548968 hasConcept C2780007028 @default.
• W2762548968 hasConcept C2780026749 @default.
• W2762548968 hasConcept C2780168065 @default.
• W2762548968 hasConcept C2780176578 @default.
• W2762548968 hasConcept C2780714102 @default.
• W2762548968 hasConcept C2781355080 @default.
• W2762548968 hasConcept C2910672364 @default.
• W2762548968 hasConcept C71924100 @default.
• W2762548968 hasConceptScore W2762548968C126322002 @default.
• W2762548968 hasConceptScore W2762548968C141071460 @default.
• W2762548968 hasConceptScore W2762548968C164705383 @default.
• W2762548968 hasConceptScore W2762548968C2775872228 @default.
• W2762548968 hasConceptScore W2762548968C2776376669 @default.
• W2762548968 hasConceptScore W2762548968C2776570981 @default.
• W2762548968 hasConceptScore W2762548968C2779303622 @default.
• W2762548968 hasConceptScore W2762548968C2780007028 @default.
• W2762548968 hasConceptScore W2762548968C2780026749 @default.
• W2762548968 hasConceptScore W2762548968C2780168065 @default.
• W2762548968 hasConceptScore W2762548968C2780176578 @default.
• W2762548968 hasConceptScore W2762548968C2780714102 @default.
• W2762548968 hasConceptScore W2762548968C2781355080 @default.
• W2762548968 hasConceptScore W2762548968C2910672364 @default.
• W2762548968 hasConceptScore W2762548968C71924100 @default.
• W2762548968 hasIssue "4" @default.
• W2762548968 hasLocation W27625489681 @default.
• W2762548968 hasLocation W27625489682 @default.
• W2762548968 hasOpenAccess W2762548968 @default.
• W2762548968 hasPrimaryLocation W27625489681 @default.
• W2762548968 hasRelatedWork W1503474841 @default.
• W2762548968 hasRelatedWork W1993832127 @default.

• next